Female infertility market expected to reach $2.3bn across the 7MM by 2033

The female infertility market is expected to grow moderately from $1.6bn in 2023 to $2.3bn in 2033, at a compound annual growth rate (CAGR) of 3.5% across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), according to GlobalData’s Female Infertility: Seven Market Drug Forecast and Market Analysis report.